Maxine Ingham, MD
Family Medicine · Las Vegas, NVNPI 1730294455
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $68.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$907
- Amgen$842
- Biogen$648
- Regeneron Healthcare Solutions, Inc.$440
- Novo Nordisk$356
- UCB, Inc.$310
- plus $2K from 22 others
Across 47 payments — averaging $74,330 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rhodes Pharmaceuticals L.p.$1.3M
- Aquestive Therapeutics, Inc.$563K
- Kindeva Drug Delivery L.p.$476K
- Apotex Inc.$468K
- Alvogen Inc$383K
- USWM, LLC$264K
- plus $28K from 3 others
What the payments were for
- Food & beverage$5,787100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $907 |
| Amgen(2 entities) | 8 | $842 |
| Biogen | 17 | $648 |
| Regeneron Healthcare Solutions, Inc. | 4 | $440 |
| Novo Nordisk | 3 | $356 |
| UCB, Inc. | 8 | $310 |
| AstraZeneca(2 entities) | 2 | $243 |
| Lucid Diagnostics Inc. | 1 | $241 |
| Novartis | 2 | $143 |
| Galderma Laboratories, L.p. | 1 | $142 |
| Teva Pharmaceuticals USA, Inc. | 2 | $142 |
| Kyowa Kirin, Inc. | 2 | $142 |
| Gilead | 2 | $137 |
| Lilly USA, LLC | 5 | $132 |
| Biohaven Pharmaceuticals, Inc. | 1 | $126 |
| Incyte Corporation | 1 | $124 |
| Sanofi | 1 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $120 |
| GSK | 1 | $119 |
| MDD US Operations, LLC | 1 | $88 |
| Jazz Pharmaceuticals Inc. | 3 | $59 |
| Johnson & Johnson | 2 | $53 |
| Genentech USA, Inc. | 3 | $36 |
| Indivior Inc. | 1 | $34 |
| GE HealthCare | 1 | $29 |
| Eisai Inc. | 1 | $24 |
| Pfizer | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,787 in reported general payments places this provider in the 90th percentile of 902 family medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alcohol Prep PadsAlcohol Antiseptic Pads | 15 | $392 |
| Losartan Potassium | 31 | $84 |
| Omeprazole | 13 | $44 |
| Chlorthalidone | 11 | $42 |
| Levothyroxine Sodium | 12 | $36 |
| Atorvastatin Calcium | 12 | $30 |
| Metformin Hcl | 17 | $28 |
| Hydrochlorothiazide | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Las Vegas
- Naz WahabLas Vegas$563K
- Jerry CadeLas Vegas$180K
- Nilesh GokalLas Vegas$75K
- Warren MagnusLas Vegas$70K
- Kimberly AdamsLas Vegas$51K
- Mandeep GillLas Vegas$24K
- Francis JimenezLas Vegas$20K
- Ryan HuangLas Vegas$18K
- Ma Francesca ChamianLas Vegas$17K
- Leo CapobiancoLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.